Advances, Breakthroughs, Controversies & Dilemmas in ART

SECTION 1 Advances and Breakthroughs in Assisted Reproduction
1. Artificial Intelligence in Assisted Reproductive Technology: The Future is Here
2. Time-lapse Monitoring: Will it Change the Assisted Reproductive Technology Outcomes
3. Implementing Total Quality Management in Assisted Reproductive Technology: Role of Witnessing and Beyond
4. Stem Cells: Will they Revolutionize Infertility Management
5. Uterine Transplantation
6. Ovarian Rejuvenation
7. Fertility Preservation in Cancer Patients and Pregnancy after Fertility Preservation
8. Oocyte and Sperm Vitrification
9. Current Practices in In Vitro Maturation
10. Endometrial Microbiota
11. Metabolomics in Assisted Reproductive Technology
12. Noninvasive Chromosomal Screening
SECTION 2 Controversies and Challenges in Assisted Reproduction
13. Polycystic Ovarian Syndrome: Role of Insulin Sensitizers
14. Poor Responders: Is There an Ideal Protocol
15. Total Fertilization Failure: What Next
16. Empty Follicle Syndrome: Causes and Further Line of Treatment
17. Supplements to Enhance Male Infertility: Are They Actually Needed
18. Advanced Sperm Selection Techniques
19. Sperm DNA Fragmentation Index: Clinical Utility and Limitations
20. Thin Endometrium: How Thin is Actually Thin
21. Endometrial Receptivity Array: Is it Beneficial
22. Intralipids and Intravenous Immunoglobulin in Infertility: Do They Actually Work
23. Recurrent Implantation Failure: Current Prospects
24. How to Choose the Best Embryo: Conventional versus Future Strategies
25. Tubal Tales Deciphered: Which Tubal Patency Test is the Best
26. Changing Perspectives of Ovarian Stimulation
27. Role of Ulipristal and Magnetic Resonance-guided Focused Ultrasound Prior to Fertility Treatment
28. Do all Uterine Septa Need Resection
SECTION 3 Dilemmas and Debates in Assisted Reproduction
29. Should Fresh Embryo Transfer be Eliminated Completely: Pros and Cons of Freeze-all
30. Varicocele: To Ligate or not to Ligate
31. How Many Embryos to Transfer: Is There a Consensus
32. Intracytoplasmic Sperm Injection: Should it be Routinely done for all
33. Hysteroscopy Before IVF: Should it be done for all
34. Noncavity-distorting Intramural Fibroids: To Remove or Not
35. Endometrioma and Infertility: To Excise or Not
36. When to Transfer? Day 3 Versus Day 5 Embryo Transfer
37. Preimplantation Genetic Testing: Should it be done for all
38. Unexplained Infertility: Should In Vitro Fertilization be the First Line of Treatment
39. Endometrial Scratching: To Do or Not to Do
Addendum
Assisted Reproductive Technology Act

Manisha Takhtani Kundnani MD FNB FNUS
Infertility and Reproductive Medicine Specialist, Scientific Director and Chief Fertility Consultant, Fertility Square - The IVF Clinic, Mumbai, Maharashtra, India
Sulbha Arora MD DNB
Clinical Director and Senior Consultant, Department of Reproductive Medicine, Nova IVF Fertility, Mumbai, Maharashtra, India